Literature DB >> 21311396

Value of preoperative pulmonary function test in flaccid neuromuscular scoliosis surgery.

Hyon Su Chong1, Eun Su Moon, Jin Oh Park, Do Yeon Kim, Phillip Anthony B Kho, Hwan Mo Lee, Sung Hwan Moon, Yong Sang Kim, Hak Sun Kim.   

Abstract

STUDY
DESIGN: Retrospective study.
OBJECTIVE: To evaluate the prognostic value of preoperative pulmonary function test (PFT) for postoperative pulmonary complications and to identify the operability associated with severely decreased forced vital capacity (FVC) (<30%) status in flaccid neuromuscular scoliosis. SUMMARY OF BACKGROUND DATA: The preoperative PFT, especially more than 30% FVC, is known as a critical factor for the operability of flaccid neuromuscular scoliosis. But only one study reported that patients with pre-existing respiratory failure on nocturnal noninvasive ventilation can undergo an operation for deformity correction without mortality and severe complications.
METHODS: A total of 74 patients (45 male and 29 female) presented with flaccid neuromuscular scoliosis. For all patients, preoperative PFTs were evaluated and subdivided into three groups (<30% FVC, 30%-50% FVC, and >50% FVC). Then postoperative pulmonary complications, pneumothorax, pneumonia, atelectasis, prolonged ventilator care in the intensive care unit (more than 72 hours), and postoperative tracheostomy were evaluated.
RESULTS: Among these patients, 59 had muscular dystrophy; 5, spinal muscular atrophy; 2, cerebral palsy; and 8, others. The mean age at surgery was 16.8 years (range, 5-32 years). The mean preoperative Cobb angle was 54.6° (16°-135°). The overall postoperative pulmonary complication rate was 31% (23 complications in 74 patients). The less than 30% FVC group had 6 complications among 18 patients; the 30% to 50% FVC group had 7 complications among 18 patients; and the more than 50% FVC group had 10 complications among 38 patients. There were no deaths during the perioperative period. There is no statistical difference between the three groups (P = 0.6195).
CONCLUSION: Patients with flaccid neuromuscular scoliosis can undergo an operation for deformity correction regardless of the severely decreased pulmonary function.

Entities:  

Mesh:

Year:  2011        PMID: 21311396     DOI: 10.1097/BRS.0b013e31820cd489

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  7 in total

1. 

Authors:  Berrin Günaydın; Ömer Kurtipek
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-06-01

2.  Intraoperative airway obstruction in a Duchenne muscular dystrophy patient.

Authors:  Jae Hyuk Yang; Amit Wasudeo Bhandarkar; Byung Gun Lim; Hitesh N Modi; Seung Woo Suh
Journal:  Eur Spine J       Date:  2013-03-17       Impact factor: 3.134

Review 3.  Successful surgery for a neuromuscular scoliosis patient by pulmonary rehabilitation with forced vital capacity below 30.

Authors:  Kai Han; Yongqian Wang; Shangbin Cui; Caixia Xu; Peiqiang Su
Journal:  Eur Spine J       Date:  2018-01-16       Impact factor: 3.134

4.  Associations between polysomnography measurements and postoperative adverse respiratory events in children with neuromuscular disease.

Authors:  Haley Fishman; Jemila S Hamid; Nick Barrowman; Franco Momoli; Ian Maclusky; Sherri Lynne Katz
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

5.  The role of preoperative pulmonary function tests in the surgical treatment of extremely severe scoliosis.

Authors:  Lifeng Lao; Xisheng Weng; Guixing Qiu; Jianxiong Shen
Journal:  J Orthop Surg Res       Date:  2013-09-05       Impact factor: 2.359

6.  Effect and mechanism of calpains on pediatric lobar pneumonia.

Authors:  Genquan Yin; Qiang Zeng; Haijin Zhao; Peiqiong Wu; Shaoxi Cai; Li Deng; Wenhui Jiang
Journal:  Bioengineered       Date:  2016-10-27       Impact factor: 3.269

7.  Peri-operative management of children with spinal muscular atrophy.

Authors:  Matthew A Halanski; Andrew Steinfeldt; Rewais Hanna; Scott Hetzel; Mary Schroth; Bridget Muldowney
Journal:  Indian J Anaesth       Date:  2020-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.